Market Overview

Top 4 Stocks In The Drug Delivery Industry With The Highest EPS Estimates For The Next Quarter

Related HSP
Will AbbVie (ABBV) Surprise This Earnings Season?
Mead Johnson (MJN) Misses on Q2 Earnings, Beats Revs
Related PETS
PetMed Posts In Line Q1 Earnings, Revenues on Lower Orders
UPDATE: PetMed Express Posts In-Line Q1 Earnings

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next quarter.

Hospira (NYSE: HSP) is estimated to post earnings of $0.51 per share in the March quarter. Hospira's trailing-twelve-month revenue is $4.01 billion.

PetMed Express (NASDAQ: PETS) is expected to earn $0.19 per share in the March quarter. PetMed Express's PEG ratio is 2.96.

Alkermes plc (NASDAQ: ALKS) is likely to earn $0.16 per share in the March quarter. Alkermes had $199.45 million in total cash for the latest quarter.

Elan Corporation plc (NYSE: ELN) may earn $0.09 per share in the March quarter. Elan's trailing-twelve-month operating margin is 11.65%.

Posted-In: Drug Delivery Industry Highest EPS EstimatesTrading Ideas

 

Most Popular

Related Articles (ALKS + ELN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters